EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

Philipp C G Paparoditis iD, Alexander Fruehwirth, Kajetana Bevc iD, Jun Siong Low iD, Josipa Jerak iD, Laura Terzaghi, Mathilde Foglierini iD, Blanca Fernandez, David Jarrossay, Davide Corti iD, Federica Sallusto iD, Antonio Lanzavecchia iD und 1 weitere

European Journal of Immunology · 2024

DOI: 10.1002/eji.202451045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Philipp C G Paparoditis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Monoclonal, Cross Reactions, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Commission of the European Communities, Seventh Framework Programme, Helmut Horten Foundation, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient identification of human monoclonal antibodies targeting specific antigenic sites is pivotal for advancing vaccines and immunotherapies against infectious diseases and cancer. Existing screening techniques, however, limit our ability to discover monoclonal antibodies with desired specificity. In this study, we introduce a novel method, blocking of binding (BoB) enzyme‐linked immunoassay (ELISA), enabling the detection of high‐avidity human antibodies directed to defined epitopes. Leveraging BoB‐ELISA, we analyzed the antibody response to known epitopes of influenza A hemagglutinin (HA) in the serum of vaccinated donors. Our findings revealed that serum antibodies targeting head epitopes were immunodominant, whereas antibodies against the stem epitope, although subdominant, were highly prevalent. Extending our analysis across multiple HA strains, we examined the cross‐reactive antibody response targeting the stem epitope. Importantly, employing BoB‐ELISA we identified donors harboring potent heterosubtypic antibodies targeting the HA stem. B‐cell clonal analysis of these donors revealed three novel, genealogically independent monoclonal antibodies with broad cross‐reactivity to multiple HAs. In summary, we demonstrated that BoB‐ELISA is a sensitive technique for measuring B‐cell epitope immunogenicity, enabling the identification of novel monoclonal antibodies with implications for enhanced vaccine development and immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, MonoclonalCross ReactionsAntibodies, ViralEnzyme-Linked Immunosorbent AssayInfluenza, HumanHumansEpitopesInfluenza VaccinesInfluenza A virus

Stichwörter der Autor:innen

AntibodiesInfectious diseasesVaccination

Substanzen

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, MonoclonalAntibodies, ViralEpitopesInfluenza Vaccines

Autor:innen und Institutionen

  • Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Institute for Microbiology, ETH Zurich, Zurich, Switzerland.
  • National Institute of Molecular Genetics, Milano, Italy.

ORCID-Profile: Philipp C G Paparoditis, Kajetana Bevc, Jun Siong Low, Josipa Jerak, Mathilde Foglierini, Davide Corti, Federica Sallusto, Antonio Lanzavecchia, Antonino Cassotta

Förderung

  • Commission of the European Communities, Seventh Framework Programme
  • Helmut Horten Foundation
  • European Research Council
  • Swiss National Science Foundation
  • H2020 European Research Council
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Paparoditis, P. C. G., Fruehwirth, A., Bevc, K., Low, J. S., Jerak, J., Terzaghi, L., Foglierini, M., Fernandez, B., Jarrossay, D., Corti, D., Sallusto, F., Lanzavecchia, A., & Cassotta, A. (2024). Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes. European Journal of Immunology. https://doi.org/10.1002/eji.202451045

Vancouver

Paparoditis PCG, Fruehwirth A, Bevc K, Low JS, Jerak J, Terzaghi L, et al. Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes. European Journal of Immunology. 2024. doi:10.1002/eji.202451045

BibTeX
@article{Paparoditis2024,
  author = {Paparoditis, Philipp C G and Fruehwirth, Alexander and Bevc, Kajetana and Low, Jun Siong and Jerak, Josipa and Terzaghi, Laura and Foglierini, Mathilde and Fernandez, Blanca and Jarrossay, David and Corti, Davide and Sallusto, Federica and Lanzavecchia, Antonio and Cassotta, Antonino},
  title = {Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202451045}
}
Kostenlos starten →